Research Article
Different Patterns of Bacterial Species and Antibiotic Susceptibility in Diabetic Foot Syndrome with and without Coexistent Ischemia
Table 4
Occurrence of particular resistance mechanisms in all analyzed bacterial strains.
| | Species and resistance mechanism | Percentage of isolated strains with the particular mechanism |
| | Acinetobacter baumannii MDR | 70.37% | | Staphylococcus aureus MRSA | 9.00% | | Staphylococcus aureus MLSB | 13.74% | | Staphylococcus aureus MRSA, MLSB | 17.06% | | Enterococcus faecalis HLAR | 21.88% | | Enterococcus faecalis HLAR, VRE () | 4.17% | | Enterococcus faecium HLAR, VRE () | 17.64% | | Enterobacter cloacae ESBL | 32.31% | | Enterobacter cloacae ESBL, AMP C () | 3.08% | | Klebsiella pneumoniae ESBL | 30% | | Klebsiella pneumoniae MBL, MDR () | 0.50% | | Escherichia coli ESBL | 9.10% | | Proteus mirabilis ESBL () | 3.20% | | Morganella morganii ESBL () | 11.76% | | Pseudomonas aeruginosa MDR, MBL () | 5.17% |
|
|
MDR: multiple drug resistant; MRSA: methicillin-resistant Staphylococcus aureus; MLSB: macrolide-lincosamide-streptogramin B resistance; HLAR: high-level aminoglycoside resistance; VRE: vancomycin-resistant enterococci; ESBL: extended spectrum beta-lactamase; AMP C: AmpC beta-lactamases; MBL: metallo-beta-lactamase.
|
